Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) - non-interventional study.
about
Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) - non-interventional study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Biosimilar Retacrit® (epoetin ...... O) - non-interventional study.
@en
type
label
Biosimilar Retacrit® (epoetin ...... O) - non-interventional study.
@en
prefLabel
Biosimilar Retacrit® (epoetin ...... O) - non-interventional study.
@en
P2093
P2860
P356
P1476
Biosimilar Retacrit® (epoetin ...... O) - non-interventional study.
@en
P2093
Christine Rudolph
Christoph Losem
Michael Koenigsmann
P2860
P304
P356
10.2147/OTT.S122427
P407
P577
2017-02-28T00:00:00Z